Patients with atrioventricular (AV) block who don’t have an indication for cardiac resynchronization therapy (CRT) do better when treated with conduction-system pacing versus right ventricular septal ...
For patients with heart failure, a reduced ejection fraction, and an indication for cardiac resynchronization therapy (CRT), using His-Purkinje conduction system pacing (HPCSP) is safe and feasible ...
Discordant results from two trials comparing conduction system pacing with biventricular pacing for cardiac resynchronization therapy (CRT) leave open the question of whether conduction system pacing ...
A 173-patient randomized trial in HFrEF (LVEF ≤35%) with LBBB (QRS ≥130 ms) showed CSP was inferior to BiVP for a hierarchical 12‑month composite endpoint. Worse outcomes with CSP were reflected by an ...
Could single-lead pacing systems for the delivery of cardiac resynchronization therapy (CRT) match or even surpass systems with three leads? Perhaps, suggest several new comparative studies, including ...
The European Society of Cardiology (ESC) has released a groundbreaking consensus statement on conduction system pacing (CSP), marking a significant milestone in the evolution of pacing therapy. The ...
A first-in-human multicenter trial found the UltiSynq CSP ICD lead, designed for left bundle branch area pacing, met and exceeded safety and effectiveness goals in over 200 patients needing ICD or CRT ...
A dedicated bipolar implantable cardioverter-defibrillator (ICD) lead for conduction system pacing (CSP) performed well in a first-in-human multicenter study. Placement of the novel UltiSynq CSP ICD ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results